drugset / Trial / NCT06344195

Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening

NCT06344195

Phase 4 Unknown 82 enrolled Dow University of Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is aimed to evaluate the efficacy of valacyclovir in reducing postoperative pain following emergency chamber opening for acute apical abscess . There will be 82 participants, (41 in each group) Group A will receive Valacyclovir Group B will receive standard treatment i.e. Naproxen Sodium. Pain level will be assessed by using Numeric rating scale for 6 days

Timeline

Start
2024-03-27
Primary completion
2024-04
Completion
2024-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule 550 mg
Subject Valacyclovir Unknown 500 mg

Indications